Trial Profile
Phase I study of ponesimod for the treatment of immunological disorders
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2015
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary)
- Indications Immunological disorders
- Focus Adverse reactions
- Sponsors Actelion Pharmaceuticals
- 02 Mar 2015 New trial record